Morgan Stanley Infra to invest ₹145 cr in HealthMaP

Our Bureau Bengaluru | Updated on May 16, 2019 Published on May 16, 2019

Morgan Stanley (File photo)   -  Bloomberg

Manipal Health Enterprise Pvt Ltd, the healthcare arm of Manipal Education and Medical Group, has announced a ₹145-crore equity commitment from Morgan Stanley India Infrastructure (MSII) in HealthMaP Diagnostics Pvt Ltd, a wholly owned subsidiary of MHEPL.

MSII will make an initial investment of ₹100 crore in HealthMaP. HealthMaP is a public-private partnership initiative for diagnostic imaging in Indian healthcare, a statement from the company said.

The core of HealthMaP’s business is a shop-in-shop model in which the company owns and operates the diagnostic imaging units inside these hospitals through exclusive long-term contracts. The company proposes to expand its footprint to 75 centres in the next three years.

With the introduction of universal healthcare in the country through the Ayushman Bharat programme, HealthMap is also exploring the opportunity to partner with private hospitals to set up facilities for diagnostics and treatment of cardiac ailments as well as cancer, and to increase access for patients especially in the underserved States, said Dilip Jose, Managing Director and CEO of Manipal Health Enterprises.

Published on May 16, 2019
This article is closed for comments.
Please Email the Editor